SCHEMBL15826554

SCHEMBL15826554

CC(C)c1cccc(C(C)C)c1N1CN(c2c(C(C)C)cccc2C(C)C)c2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.43
MGLL Q99685 1/20 0.43
ALOX15 P16050 2/20 0.42
DPP4 P27487 5/20 0.40
GABRA1 P14867 3/20 0.40
GABRB2 P47870 2/20 0.40
TSHR P16473 2/20 0.40
GABRG2 P18507 2/20 0.40
GABRB3 P28472 2/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
GABRB1 P18505 1/20 0.40
PTGS1 P23219 1/20 0.40
SLC6A2 P23975 1/20 0.40
HTR2C P28335 1/20 0.40
GABRA5 P31644 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30265954 1.00 FAAH (0.43) FAAHMGLLALOX15DPP4GABRA1
SCHEMBL21037141 0.87 LMNA (0.41) FAAHMGLLALOX15DPP4TSHR
SCHEMBL17173375 0.82 ALDH1A1 (0.39) FAAHMGLLALOX15TSHRALDH1A1
SCHEMBL2598717 0.82 GABRA1 (0.41) FAAHALOX15DPP4GABRA1GABRB2
SCHEMBL18964727 0.80 ALOX15 (0.33) FAAHMGLLALOX15DPP4GABRA1
Hydrochloric Acid SCHEMBL818414 0.80 GABRA1 (0.40) FAAHALOX15DPP4GABRA1GABRB2
SCHEMBL760008 0.80 LMNA (0.40) FAAHALOX15DPP4GABRA1GABRB2
SCHEMBL2900268 0.80 GABRA1 (0.40) FAAHALOX15DPP4GABRA1GABRB2
Bromide SCHEMBL2895695 0.80 GABRA1 (0.40) FAAHALOX15DPP4GABRA1GABRB2
SCHEMBL20408268 0.79 HTR7 (0.43) FAAHMGLLALOX15DPP4NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12291506-B2 Method for producing amidate compound, and amidate compound KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-05-06 US disclosed
US-20230295368-A1 CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT KOEI CHEMICAL COMPANY, LIMITED (JP) 2023-09-21 US disclosed
US-11765967-B2 Highly efficient OLED devices with very short decay times UDC IRELAND LIMITED (IE) 2023-09-19 US disclosed
US-11765967-B2 Highly efficient OLED devices with very short decay times UDC IRELAND LIMITED (IE) 2023-09-19 US disclosed
US-20230250111-A1 CARBENE COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICES UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2023-08-10 US disclosed
US-11718704-B2 Catalyst for dissociation of blocking agent for blocked isocyanates, and thermosetting composition containing said catalyst for dissociation of blocking agent KOEI CHEMICAL COMPANY, LIMITED (JP) 2023-08-08 US disclosed
US-20220149300-A1 HIGHLY EFFICIENT OLED DEVICES WITH VERY SHORT DECAY TIMES UDC IRELAND LTD (IE) 2022-05-12 US disclosed
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND KOEI CHEMICAL COMPANY, LIMITED (JP) 2022-02-17 US disclosed
EP-3878855-A1 CARBENE COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICES University of Southern California (US) 2021-09-15 EP disclosed
EP-3858817-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND Koei Chemical Company, Limited (JP) 2021-08-04 EP disclosed
US-11075346-B2 Highly efficient OLED devices with very short decay times UDC IRELAND LIMITED (IE) 2021-07-27 US disclosed
EP-3489243-B1 CARBENE COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICES UNIV SOUTHERN CALIFORNIA (US) 2021-04-21 EP disclosed
EP-3689931-A1 CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT Koei Chemical Company, Limited (JP) 2020-08-05 EP disclosed
US-20200216600-A1 CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT KOEI CHEMICAL COMPANY, LIMITED (JP) 2020-07-09 US disclosed
US-20200044165-A1 HIGHLY EFFICIENT OLED DEVICES WITH VERY SHORT DECAY TIMES UDC IRELAND LTD (IE) 2020-02-06 US disclosed
EP-3489243-A1 CARBENE COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICES University of Southern California (US) 2019-05-29 EP disclosed
US-20170170420-A1 ORGANIC ELECTROLUMINESCENCE DEVICE CANON KABUSHIKI KAISHA (JP) 2017-06-15 US disclosed
US-20150337070-A1 METHOD FOR PRODUCING FORMALDEHYDE/CO2 COPOLYMERS BAYER MATERIALSCIENCE AG (DE) 2015-11-26 US disclosed
EP-2938651-A2 METHOD FOR PRODUCING FORMALDEHYDE/CO2 COPOLYMERS Covestro Deutschland AG (DE) 2015-11-04 EP disclosed
WO-2014095861-A2 METHOD FOR PRODUCING FORMALDEHYDE/CO2 COPOLYMERS BAYER MATERIALSCIENCE AG (DE) 2014-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12291506-B2 Method for producing amidate compound, and amidate compound NAAA, NIT2, PAM FAAH 229/4885MGLL 669/4885ALOX15 2539/4885
US-20230295368-A1 CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT IDH3A, RCOR1, MUS81 FAAH 502/4885MGLL 2288/4885ALOX15 3527/4885
US-20230250111-A1 CARBENE COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICES CYCS, SCO2, UQCRB FAAH 3735/4885MGLL 4236/4885ALOX15 1264/4885
US-11718704-B2 Catalyst for dissociation of blocking agent for blocked isocyanates, and thermosetting composition containing said catalyst for dissociation of blocking agent IDH3A, RCOR1, MUS81 FAAH 502/4885MGLL 2288/4885ALOX15 3527/4885
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND NAAA, NIT2, PAM FAAH 229/4885MGLL 669/4885ALOX15 2539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.